• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Medical Device Problem Codes Material Rupture (1546); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/27/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that there was a pinhole rupture in the balloon.A ranger global dcb otw 6.0 x 200mm, 90cm was selected for use in the endovascular therapy (evt) procedure.The target lesion was within the moderately tortuous superficial femoral artery (sfa) and was reported to be 100% stenosed with moderate calcification.The ranger was advanced to the target lesion and inflated for the first time to 6 atm before bursting.The form of the rupture was reported to be a pinhole.The device was retracted without issue.The ranger was replaced and the procedure was completed.There were no reported adverse consequences to the patient.
 
Additional Manufacturer Narrative
(b)(6).
 
Additional Manufacturer Narrative
E1 - initial reporter state: (b)(6).
 
Event or Problem Description
It was initially reported that there was a pinhole rupture in the balloon.However, on 28nov2022, additional information was received that indicated there was no longer any allegation of device deficiency.The initial report of pinhole rupture had been misreported by the sales representative.Therefore, the event no longer meets complaint criteria.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Common Device Name
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15840166
Report Number2124215-2022-46073
Device Sequence Number6901761
Product Code ONU
UDI-Device Identifier08714729976219
UDI-Public08714729976219
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P190019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/15/2024
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number02425H22
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 10/27/2022
Supplement Date Received by Manufacturer11/28/2022
Initial Report FDA Received Date11/21/2022
Supplement Report FDA Received Date12/22/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/16/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-